Evidence map›Paper›PMID 37728319›Full record

ArticleeLife2023

SIRT2 inhibition protects against cardiac hypertrophy and ischemic injury.

Xiaoyan Yang, Hsiang-Chun Chang, Yuki Tatekoshi, Amir Mahmoodzadeh, Maryam Balibegloo, Zeinab Najafi, Rongxue Wu, Chunlei Chen, Tatsuya Sato, Jason Shapiro and 1 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Xiaoyan Yang *Feinberg Cardiovascular and Renal Research Institute, Northwestern University School of Medicine, Chicago, United States.ORCID 0000-0002-4450-7554
Hsiang-Chun Chang *Feinberg Cardiovascular and Renal Research Institute, Northwestern University School of Medicine, Chicago, United States.
Yuki Tatekoshi *Feinberg Cardiovascular and Renal Research Institute, Northwestern University School of Medicine, Chicago, United States.
Amir MahmoodzadehFeinberg Cardiovascular and Renal Research Institute, Northwestern University School of Medicine, Chicago, United States.ORCID 0000-0002-0523-8152
Maryam BalibeglooFeinberg Cardiovascular and Renal Research Institute, Northwestern University School of Medicine, Chicago, United States.
Zeinab NajafiFeinberg Cardiovascular and Renal Research Institute, Northwestern University School of Medicine, Chicago, United States.
Rongxue WuFeinberg Cardiovascular and Renal Research Institute, Northwestern University School of Medicine, Chicago, United States.
Chunlei ChenFeinberg Cardiovascular and Renal Research Institute, Northwestern University School of Medicine, Chicago, United States.
Tatsuya SatoFeinberg Cardiovascular and Renal Research Institute, Northwestern University School of Medicine, Chicago, United States.ORCID 0000-0001-7876-1772
Jason ShapiroFeinberg Cardiovascular and Renal Research Institute, Northwestern University School of Medicine, Chicago, United States.ORCID 0000-0003-0880-3142
Hossein ArdehaliFeinberg Cardiovascular and Renal Research Institute, Northwestern University School of Medicine, Chicago, United States.ORCID 0000-0002-7662-0551
Renal Research Institute · US

Funding

Mechanistic insights into HIV-mediated heart failure with preserved ejection fractionR01HL140973 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ARDEHALI, HOSSEIN · 2018 to 2021
$2.6M
Mechanistic insights into the deleterious effects of SIRT2 in the heart under stress conditionsR01HL138982 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ARDEHALI, HOSSEIN · 2018 to 2021
$2.3M
Role of mRNA-binding protein tristetraprolin in cardiac mRNA regulation and the development of heart failureR01HL155953 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WEINBERG, SAMUEL · 2022 to 2025
$2.3M
Mechanistic insights into the role of mitochondrial iron in doxorubicin-induced cardiomyopathy using human induced pluripotent stem cellsR01HL140927 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ARDEHALI, HOSSEIN · 2020 to 2023
$1.6M
NHLBI NIH HHS R01 HL138982NHLBI NIH HHS R01 HL140927NHLBI NIH HHS R01 HL140973NHLBI NIH HHS R01 HL155953
6 · The paper itself

Abstract

Sirtuins (SIRT) exhibit deacetylation or ADP-ribosyltransferase activity and regulate a wide range of cellular processes in the nucleus, mitochondria, and cytoplasm. The role of the only sirtuin that resides in the cytoplasm, SIRT2, in the development of ischemic injury and cardiac hypertrophy is not known. In this paper, we show that the hearts of mice with deletion of

Indexed as

NF-E2-Related Factor 2Sirtuin 2AnimalsCardiomegalyIschemiaMiceMyocytes, CardiacNF-E2-Related Factor 2Sirt2 protein, mouseSirtuin 2cardiac hypertrophyheart failuremedicinemousesirtuins

Identifiers

PMID37728319
PMCPMC10558204
OpenAlexW4386878711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.